Yuan, D., Zhu, F., Zuo, R., Wang, Y., Huo, G., Cui, J., . . . Chen, P. (2023). High incidence and reversible bradycardia events following alectinib initiation. Thoracic Cancer, 14(5), 479. https://doi.org/10.1111/1759-7714.14769
Chicago Style (17th ed.) CitationYuan, Dongqi, Fuyi Zhu, Ran Zuo, Yu Wang, Gengwei Huo, Jinfang Cui, Ping Yue, and Peng Chen. "High Incidence and Reversible Bradycardia Events Following Alectinib Initiation." Thoracic Cancer 14, no. 5 (2023): 479. https://doi.org/10.1111/1759-7714.14769.
MLA (9th ed.) CitationYuan, Dongqi, et al. "High Incidence and Reversible Bradycardia Events Following Alectinib Initiation." Thoracic Cancer, vol. 14, no. 5, 2023, p. 479, https://doi.org/10.1111/1759-7714.14769.
Warning: These citations may not always be 100% accurate.